Approval · Notice of Compliance 28398 · 2022
LETYBO: Notice of Compliance 28398
Issued June 14, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28398
- Date
- June 14, 2022
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- LETIBOTULINUMTOXINA 50 UNIT per VIAL
- LETIBOTULINUMTOXINA 100 UNIT per VIAL